1. CHR S PRING R ESEARCH U PDATE Norbert Gleicher, MD David H. Barad, MD, MS

2. G ENETICALLY PROGRAMMED ( PREMATURE ) OVARIAN AGING : THE FMR1 GENE.

5. D ISTRIBUTION OF CGG T RIPLE R EPEAT E XPANSIONS ON THE FMR1 IN THE W HOLE S TUDY P OPULATION OF I NFERTILE W OMEN IN C OMPARISON WITH A G ENERAL P OPULATION The figure demonstrates the distributions of CGG triple repeat counts on allele-1 (interrupted line) and allele-2 (solid line) against the shaded background distribution curve reported by Fu et al for a general population. Infertile women demonstrate a mild shift for allele-1and much clearer shift for allele-2 towards higher triple repeats.

6. L OGISTIC R EGRESSIONS IN G ROUPS A AND C The figure represents logistic regressions, demonstrating predicted relative risk (RR) of having AMH of less than 0.8 ng/ml over CGG repeat counts, stratified by age. Blue dots (and blue line) represent women ≥ 38 years of age; Red dots (and green line) represent age < 38 years. The black line reflects women of all ages. RR of diminished ovarian reserve, as reflected by AMH, progressively increases in the presence of CGG counts below and above 30 repeats. For every 5 repeat decrease in CGG count below 30, the relative risk of low AMH increases by 60%. For every 5 repeat increase in CGG repeat count above 30 the relative risk of low AMH is increased by 40%.

7. T RIPLE CGG C OUNTS BY B OX AND W HISKER P LOT FOR E NTIRE P ATIENT P OPULATION

8. T RIPLE CGG C OUNTS BY B OX AND W HISKER P LOTS FOR I NDIVIDUAL R ACIAL /E THNIC G ROUPS

9. H ETEROZYGOUS VS. H OMOZYGOUS

10. Normal CGG range: 26-32 Median CGG count: 30

11. B OX AND W HISKER P LOT, D EFINING N ORMAL AMH L EVELS AND O UTLIERS The figure reflects AMH levels in egg donors and infertility patients based on zygosity in women under age 38 years, when physiological diminution of ovarian reserve due to advancing age affects ovarian function only to a lesser degree. * Denotes one allele in normal count range (26-33) and one allele outside of normal range. ** Denotes both alleles outside of normal range. A reflects egg donors and B infertility patients. The bold horizontal line within each box reflects the median value. AMH values in egg donors did not vary statistically, though they seem to mildly trend upwards from normal to heterozygous and homozygous. Amongst infertility patients results differed significantly between the three patient groups (p=0.032). Specifically, homozygous women demonstrated significantly lower AMH levels than normal patients (p=0.009) and a strong trend towards lower levels in comparison to heterozygous women (p=0.063).

12. L INEAR R EGRESSION OF A SSOCIATION BETWEEN AMH L EVELS AND A GE B ASED ON FMR1 S TATUS The figure represents egg donors and infertility patients at all ages. Normal females at young ages have the highest, and women with homozygous CGG count abnormalities the lowest AMH levels. AMH levels, however, decline in normal women more rapidly than in heterozygous and homozygous patients. At approximately 35 years of age AMH levels in heterozygous women start to exceed those of normal women. AMH levels in homozygous women track those of normal women almost till age 50, when they start exceeding the latter.

13. AMH L EVELS IN B INNED A GE G ROUPS B ASED ON FMR1 S TATUS The figure represents egg donors and infertility patients of all ages. Under age 30years AMH levels significantly differ amongst all three patient groups (p=0.009). Specifically, AMH in normal women is significantly higher between normal women and homozygous females (p<0.001) and between heterozygous and homozygous patients (p=0.002). By age 34.99, these statistical differences no longer are present.

14. Barad et al. Obstet Gynecol 2007: 109; 1404-10.

15. P REVIOUSLY R EPORTED R EPRODUCTIVE B ENEFITS OF DHEA  Improves egg/embryo numbers  Improves egg/embryo quality  Improves spontaneous pregnancy rates  Improves IVF pregnancy rates  Improves time to conception  Improves cumulative pregnancy rates Carson et al. Hum Reprod 2000 Barad and Gleicher, Hum Reprod 2006 Barad and Gleicher, Fertil Steril 2005Barad et al, J Assist Reprod Genet 2007

16. S URVIVAL F UNCTION FOR C UMULATIVE F AILURE TO C ONCEIVE S TRATIFIED BY A GE Cumulative Failure to Conceive Months Since Starting DHEA 02 8 64 1.2 1.0.8.2.4.6 AGE >=42 38 ->42 <38

17. Cumulative pregnancy rate based on Cox regression of time from initial visit to clinical pregnancy or censor by DHEA use stratified by ovarian reserve and adjusted for ART treatment, race/ethnicity, age and baseline FSH (HR 3.8; 95% CI 1.2-11.8; p<0.05) P REMATURE O VARIAN A GING Diminished Ovarian Reserve DHEA Control Months from Initial Visit Cumulative Pregnancy 0.5 0.4 0.3 0.2 0.1 0.0 0.5 0.4 0.3 0.2 0.1 0.0 0 2 4 6 8 10 Barad et al. J Assist Reprod Genet 2007: 24; 629-634.

18. Comparison of Miscarriage Rates between DHEA Supplemented Infertility Patients and 2004 National US IVF Outcome Data.

19. AMH INHIBITS RECRUITMENT AND GROWTH La Marca & Volpe: Clinical Endocrinology (2006) 64, 603–610

20. AMH IS STABLE ACROSS THE MENSTRUAL CYCLE

21. AMH / FSH AND AGE N OMOGRAM

22. R ETRIEVALS ( BY YEAR AND AGE )

23. AMH BY A GE C ATEGORY

24. P ERCENT R ETRIEVALS BY A GE AND Y EAR

25. R ETRIEVALS PER Y EAR % BY A GE